PO-1157: Short-term results of coverage probability radiotherapy of MRI-staged prostate cancer.

MLA

Marzec, J., et al. “PO-1157: Short-Term Results of Coverage Probability Radiotherapy of MRI-Staged Prostate Cancer.” Radiotherapy & Oncology, vol. 152, Nov. 2020, p. S609. EBSCOhost, https://doi.org/10.1016/S0167-8140(21)01175-0.

APA

Marzec, J., Eisenmann, R., Paulsen, F., Wegener, D., Frey, B., Zamboglou, C., Othman, A., Nikolaou, K., Alber, M., Dohm, O., Thorwarth, D., Zips, D., & Müller, A. (2020). PO-1157: Short-term results of coverage probability radiotherapy of MRI-staged prostate cancer. Radiotherapy & Oncology, 152, S609. https://doi.org/10.1016/S0167-8140(21)01175-0

Chicago

Marzec, J., R. Eisenmann, F. Paulsen, D. Wegener, B. Frey, C. Zamboglou, A. Othman, et al. 2020. “PO-1157: Short-Term Results of Coverage Probability Radiotherapy of MRI-Staged Prostate Cancer.” Radiotherapy & Oncology 152 (November): S609. doi:10.1016/S0167-8140(21)01175-0.